Anti-PCNA - DyLight® 550

Leinco Technologies
Product Code: LEI-P331
Product Group: Primary Antibodies
CodeSizePrice
LEI-P331-50ug50 ug£159.00
Quantity:
LEI-P331-100ug100 ug£211.00
Quantity:
LEI-P331-200ug200 ug£291.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Mouse
Antibody Isotype: IgG2a κ
Antibody Clonality: Monoclonal
Antibody Clone: PC10
Regulatory Status: RUO
Target Species: Rat
Application: Flow Cytometry
Shipping:
2-8°C
Storage:
This DyLight® 550 conjugate is stable when stored at 2-8°C. Do not freeze.

Further Information

Antigen Distribution:
PCNA is a ubiquitous nuclear protein present in all cell cycle stages, with the highest expression in the early S phase. Anti-PCNA staining is almost entirely confined to the nucleus and may show a diffuse or granular pattern or a mixture of both.
Concentration:
0.2 mg/ml
Conjugate/Tag/Label:
DyLight® 550
Format:
This DyLight® 550 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Formulation:
This DyLight® 550 conjugate is formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.4, 1% BSA and 0.09% sodium azide as a preservative.
Immunogen:
Rat PCNA made in the protein A vector pR1T2T
Long Description:
PCNA antibody, clone PC10, recognizes proliferating cell nuclear antigen (PCNA), also known as cyclin, a 36 kDa nuclear protein belonging to the DNA sliding clamp family. PCNA is a ring-shaped homotrimer that encircles and slides along DNA1,2. PCNA is an auxiliary protein of DNA polymerase δ and ε and tethers the polymerase catalytic unit to the DNA template for efficient DNA synthesis3-6. PCNA also contributes to chromatin remodeling, DNA repair, sister chromatid cohesion, and cell cycle control7. Expression levels of PCNA are associated with proliferation and transformation, and PCNA is commonly used as a marker for proliferating cells8,9. Antibodies to PCNA are detected in sera from patients with systemic lupus erythematosus (SLE)10. In addition, PCNA is a reliable diagnostic and prognostic biomarker for cancer, as tumor cells express high levels of PCNA11.
NCBI Gene:
5111
Target:
PCNA

References

1. Krishna TS, et al. (1994) Cell. 79(7):1233-43 2. Schurtenberger P, et al. (1998) J Mol Biol. 275(1):123-32 3. Kelman, Z. (1997) Oncogene. 14, 629?640 4. Tan CK, et al. (1986) J Biol Chem. 261(26):12310-6 5. Bravo R, et al. (1987) Nature. 8;326(6112):515-7 6. Prelich G, et al. (1987) Nature. 8;326(6112):517-20 7. Maga G, Hubscher U. (2003) J Cell Sci. 116(Pt 15):3051-60 8. Bravo R, et al. (1982) Prog Clin Biol Res. 85 Pt A:235-48. 9. Celis JE, et al. (1984) Leuk Res. 8(2):143-57 10. Miyachi K, et al. (1978) J Immunol. 121(6):2228-34. 11. Naryzhny SN, Lee H. (2007) FEBS Lett.581(25):4917-20